Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Feb 14, 2024

SELL
$1.39 - $1.72 $326 - $404
-235 Reduced 75.08%
78 $0
Q3 2023

Nov 14, 2023

SELL
$1.39 - $1.72 $326 - $404
-235 Reduced 75.08%
78 $0
Q2 2023

Feb 14, 2024

BUY
$1.7 - $2.6 $399 - $611
235 Added 301.28%
313 $0
Q2 2023

Aug 10, 2023

BUY
$1.7 - $2.6 $532 - $813
313 New
313 $0
Q4 2022

Feb 07, 2023

BUY
$3.27 - $5.5 $647 - $1,089
198 New
198 $1,000
Q2 2022

Aug 11, 2022

BUY
$5.62 - $7.5 $275 - $367
49 New
49 $0
Q1 2022

May 09, 2022

SELL
$5.7 - $8.2 $1,316 - $1,894
-231 Closed
0 $0
Q4 2021

Feb 04, 2022

BUY
$6.48 - $8.66 $1,406 - $1,879
217 Added 1550.0%
231 $1,000
Q3 2021

Nov 08, 2021

BUY
$5.4 - $7.55 $75 - $105
14 New
14 $0

Others Institutions Holding INCR

About Intercure Ltd.


  • Ticker INCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,133,900
  • Market Cap $76.7M
  • Description
  • InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector. InterCure Ltd. was incorporated in 1994 a...
More about INCR
Track This Portfolio

Track Toronto Dominion Bank Portfolio

Follow Toronto Dominion Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Toronto Dominion Bank, based on Form 13F filings with the SEC.

News

Stay updated on Toronto Dominion Bank with notifications on news.